Ameritas Investment Partners’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130K | Buy |
13,839
+1,330
| +11% | +$11.9K | ﹤0.01% | 1665 |
|
|
2026
Q1 | $102K | Hold |
12,509
| – | – | ﹤0.01% | 1693 |
|
|
2025
Q4 | $84.1K | Hold |
12,509
| – | – | ﹤0.01% | 1802 |
|
|
2025
Q3 | $108K | Sell |
12,509
-3,617
| -22% | -$28.1K | ﹤0.01% | 1642 |
|
|
2025
Q2 | $102K | Hold |
16,126
| – | – | ﹤0.01% | 1750 |
|
|
2025
Q1 | $103K | Hold |
16,126
| – | – | ﹤0.01% | 1679 |
|
|
2024
Q4 | $130K | Buy |
16,126
+2,287
| +17% | +$22K | ﹤0.01% | 1612 |
|
|
2024
Q3 | $175K | Sell |
13,839
-350
| -2% | -$4.52K | 0.01% | 1408 |
|
|
2024
Q2 | $180K | Buy |
14,189
+2,891
| +26% | +$29.1K | 0.01% | 1344 |
|
|
2024
Q1 | $54K | Buy |
11,298
+2,711
| +32% | +$12.6K | ﹤0.01% | 2108 |
|
|
2023
Q4 | $41.2K | Hold |
8,587
| – | – | ﹤0.01% | 2280 |
|
|
2023
Q3 | $62.2K | Buy |
8,587
+1,397
| +19% | +$11.2K | ﹤0.01% | 1969 |
|
|
2023
Q2 | $53.4K | Buy |
+7,190
| New | +$56.5K | ﹤0.01% | 2009 |
|
|
2021
Q2 | – | Sell |
-5,084
| Closed | -$922K | – | 3175 |
|
|
2021
Q1 | $922K | Sell |
5,084
-79
| -2% | -$15.7K | 0.04% | 624 |
|
|
2020
Q4 | $576K | Sell |
5,163
-90
| -2% | -$9.57K | 0.03% | 727 |
|
|
2020
Q3 | $569K | Buy |
5,253
+104
| +2% | +$12.7K | 0.03% | 681 |
|
|
2020
Q2 | $429K | Buy |
5,149
+2,823
| +121% | +$108K | 0.02% | 746 |
|
|
2020
Q1 | $32K | Buy |
2,326
+690
| +42% | +$5.84K | ﹤0.01% | 1911 |
|
|
2019
Q4 | $7K | Hold |
1,636
| – | – | ﹤0.01% | 2841 |
|
|
2019
Q3 | $8K | Hold |
1,636
| – | – | ﹤0.01% | 2815 |
|
|
2019
Q2 | $10K | Sell |
1,636
-1
| -0.1% | -$8 | ﹤0.01% | 2804 |
|
|
2019
Q1 | $18K | Hold |
1,637
| – | – | ﹤0.01% | 2436 |
|
|
2018
Q4 | $60K | Hold |
1,637
| – | – | ﹤0.01% | 1700 |
|
|
2018
Q3 | $62K | Hold |
1,637
| – | – | ﹤0.01% | 1867 |
|
|
2018
Q2 | $44K | Buy |
1,637
+308
| +23% | +$10.4K | ﹤0.01% | 2074 |
|
|
2018
Q1 | $56K | Buy |
1,329
+295
| +29% | +$11.9K | ﹤0.01% | 1866 |
|
|
2017
Q4 | $26K | Hold |
1,034
| – | – | ﹤0.01% | 2311 |
|
|
2017
Q3 | $21K | Hold |
1,034
| – | – | ﹤0.01% | 2392 |
|
|
2017
Q2 | $24K | Hold |
1,034
| – | – | ﹤0.01% | 2356 |
|
|
2017
Q1 | $26K | Hold |
1,034
| – | – | ﹤0.01% | 2261 |
|
|
2016
Q4 | $26K | Hold |
1,034
| – | – | ﹤0.01% | 1154 |
|
|
2016
Q3 | $43K | Hold |
1,034
| – | – | ﹤0.01% | 1108 |
|
|
2016
Q2 | $150K | Hold |
1,034
| – | – | 0.01% | 969 |
|
|
2016
Q1 | $107K | Hold |
1,034
| – | – | 0.01% | 987 |
|
|
2015
Q4 | $174K | Hold |
1,034
| – | – | 0.01% | 944 |
|
|
2015
Q3 | $146K | Hold |
1,034
| – | – | 0.01% | 944 |
|
|
2015
Q2 | $230K | Sell |
1,034
-14
| -1% | -$2.46K | 0.02% | 925 |
|
|
2015
Q1 | $173K | Hold |
1,048
| – | – | 0.01% | 1019 |
|
|
2014
Q4 | $124K | Hold |
1,048
| – | – | 0.01% | 1025 |
|
|
2014
Q3 | $87K | Buy |
1,048
+110
| +12% | +$9.94K | 0.01% | 1015 |
|
|
2014
Q2 | $87K | Buy |
938
+133
| +17% | +$11.7K | 0.01% | 1048 |
|
|
2014
Q1 | $73K | Hold |
805
| – | – | 0.01% | 1030 |
|
|
2013
Q4 | $82K | Buy |
805
+290
| +56% | +$20.5K | 0.01% | 1024 |
|
|
2013
Q3 | $33K | Buy |
+515
| New | +$29K | ﹤0.01% | 994 |
|
Other funds holding NVAX
SCM
S
Ameritas Investment Partners's NVAX Position: Q2 2026 in Review
Ameritas Investment Partners increased its Novavax (NVAX) stake by 11% in Q2 2026, buying an estimated $11.9K and bringing the position to 13,839 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.
Ameritas Investment Partners first reported a position in NVAX in Q3 2013 and has held it in 44 quarters since. The position peaked at $922K in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Ameritas Investment Partners held 13,839 shares of Novavax worth $130K as of Q2 2026.
- Ameritas Investment Partners bought 1,330 Novavax shares in Q2 2026, an estimated $11.9K.
- Novavax made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1665 holding.
- Ameritas Investment Partners first reported a position in Novavax in Q3 2013 and has held it in 44 quarters since.
- Ameritas Investment Partners's Novavax position peaked at $922K in Q1 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.